Expression level and clinical features of STAT3 in breast cancer
10.3969/j.issn.1006-5725.2017.12.019
- VernacularTitle:STAT3在乳腺癌中的表达及临床意义
- Author:
Qingtao WANG
;
Haiyang HUANG
;
Qingfeng ZOU
;
Xinghui DENG
- Keywords:
STAT3;
Immuneohistochemisty;
Breast cancer
- From:
The Journal of Practical Medicine
2017;33(12):1972-1975
- CountryChina
- Language:Chinese
-
Abstract:
Objective To detect the expression of STAT3 in breast cancer and adjacent paracancerous tissues ,then analyze the correlationship between its expression level and some other clinical features of breast cancer,and to evaluate its significance in prognosis of patients with breast cancer. Methods 130 breast cancer patients were enrolled in the Jiangmen Central Hospital ,and 61 cases of adjacent normal tissues. The expression of STAT3 was detected by IHC. We compared the expression of STAT3 between the two groups and analyzed the relationship between STAT3 and other clinical features. Results The expression of STAT3 in breast cancer group was much higher than the adjacent paracancerous tissues. STAT3 expression showed obvious correlationship with clinical stage ,tumor size ,lymph node metastasis ,the expression of ER and PR ,but no statistical correla-tion with age ,histological grade and Her-2 expression. Survival analysis showed that patients with high STAT3 expression level had a significantly poor prognosis. The Cox regression analysis showed that PR and STAT3 expres-sion were independent prognostic factors for patients with breast cancer. Conclusion These results may implicate that STAT3 will promote the development of breast cancer and higher expression of STAT3 indicates the poor survival rate.
